Clinical Research
SHP is a research active practice. What does this mean?
Clinical research means patients get access to new treatments, interventions and medicines. Investment in research means better, more cost effective care for patients.
According to the NHS Constitution, research is a core function of the NHS.
Clinical research is a major driver of innovation and central to NHS practice for maintaining and developing high standards of patient care.
Evidence suggests that research active practices have better clinical outcomes.
- It offers patients access to new treatments, interventions and medicines
- It brings a new dimension to practice and added skills to those involved
- It provides national gold standard training for research
- Investment in research means better, more cost effective care for patients.
You might want to get involved in research to:
- learn more about a condition that affects you
- make a difference, by helping to improve treatments and quality of life, now and for future generations
- support medical research for a particular condition or disease that you care about
- access new treatments
- take an active role in your own care.
There are various ways a patient can become involved in studies:
- A doctor or nurse may talk to you about a particular study and ask whether you would be interested in participating
- You may be sent information through via text message or post if we feel you may be a suitable participant
- You may read information about a current study in the patient waiting room or on the surgery website and wish to take part by contacting your GP.
Your health records contain a type of data called confidential patient information. This data can be used to help with research and planning.
You can choose to stop your confidential patient information being used for research and planning. You can also make a choice for someone else like your children under the age of 13. Read more here
If you choose to stop your confidential patient information being used for research and planning, your data might still be used in some situations. Read more here
You can read SHP's Privacy Policy here
uMed
Solihull Healthcare Partnership is currently working with a research technology partner
known as uMed. Their accredited platform enables us to provide you with research
opportunities that are highly relevant to your health circumstances.
Without the use of uMed’s technology we may not have the time to find and engage patients
that meet the requirements of the studies. This would therefore mean many patients would
miss out on their chance to participate in ground-breaking research.
For further information on uMed please visit their website at www.umed.io or email
patientsupport@umed.io
Solihull Healthcare Partnership uses Umedeor Ltd (uMed) as a data processor to support
research and care support activity. This includes accessing and secure hosting of health
record data for the purpose of identifying patients that are eligible for specific research or
care support projects. uMed also contacts those patients on behalf of the practice via SMS,
letter, email or telephone to provide more information about the study, and to collect
additional information to assess your eligibility for a certain study.
Your consent will be required before any practice data is shared externally with researchers.
uMed applies the national opt-out to practice data it receives so if you wish your data is not
processed for research you can do so by visiting https://www.nhs.uk/your-nhs-data-matters/
Your participation is entirely voluntary and can be withdrawn by yourself at any time without an explanation required.
You are under no obligation to participate in any research project.
Your care and your relationship with your doctor or nurse will not be affected in any way if you decided not to take part in a research study.
You will always receive clear information about what taking part in a research study would involve.
You will have the opportunity to ask questions and obtain further details about a study.
If you do agree to take part in a study you will be asked to sign a consent form, this will clearly state which parts of your notes (if any) may be looked at for the purposes of the research study.
Nobody from outside this Practice will be given your contact details or have access to your medical notes without your prior consent
National Data Opt Out
The national data opt-out was introduced on 25 May 2018, enabling patients to opt out from the use of their data for research or planning purposes, in line with the recommendations of the National Data Guardian.
Patients can view or change their national data opt-out choice at any time by using the online service at www.nhs.uk/your-nhs-data-matters or by clicking on “Your Health” in the NHS App, and selecting “Choose if data from your health records is shared for research and planning”.
Once you have made your choice using the methods above - SHP will be notified of your decision and you will not be contacted about any future clinical research studies.
Current Research Studies
The FLASH Study
Although there are several treatment options already available for asthma, some individuals
may still have difficulty controlling their symptoms.
Solihull Healthcare Partnership is taking part in the FLASH study which is investigating
whether a medication called Atuliflapon can improve symptoms for patients living with
moderate to severe uncontrolled Asthma.
This study is recruiting male and female participants between the age of 18-55 years of age
with a confirmed asthma diagnosis.
Solihull Healthcare Partnership is working with our research technology partner uMed to
invite patients to this study. If you meet the study criteria, you may receive a text message,
email or letter asking whether you would like to take part. Participation is entirely voluntary
and you can opt out at any time.
If you have any questions about this study please contact the uMed nurse support team at
patientsupport@umed.io.
This research opportunity is invite only - You will be contacted if you are eligible
What is the purpose of the study
The aim of this study is to find out whether these newer blood thinning tablets can prevent serious long-term complications if used earlier in patients with AF. We are also testing a new way to run trials within the NHS, based locally in GP surgeries and without the need for patients to visit a hospital.
This research opportunity is invite only - You will be contacted if you are eligible
This research opportunity is invite only - You will be contacted if you are eligible
Vaccine Studies
The E.mbrace Study will assess the effectiveness and safety of an investigational vaccine in the prevention of blood infections in adults aged 60 or over.
This research opportunity is invite only - You will be contacted if you are eligible through SHP. The study will take place at FutureMeds, 247-251 Soho Rd, Birmingham, B21 9RY, UK.
Research Study Opportunities
(Follow the links below to register your interest)
When you sign up to Join Dementia Research, the information you provide is used to match you to studies you may be able to take part in, both online, nationally and in your local area. The service connects registered volunteers with dementia researchers across the UK who are looking for people to join their studies.
You can review your study matches once you register and then it’s your decision whether to take part. Taking part means you will make a real difference to the future of dementia care, diagnosis and treatment.
Dementia affects more than 850,000 people in the UK.
Research offers hope. Only through research can we understand what causes dementia diseases, develop effective treatments and improve the care of those living with dementia.
To find out more and to register, visit https://www.joindementiaresearch.nihr.ac.uk/
MyMelanoma is the largest melanoma research study in the world.
It is a partnership between people who have been affected by melanoma, clinicians and researchers.
MyMelanoma is designed to answer the most important unanswered questions in melanoma research, which have been identified by people affected by melanoma.
MyMelanoma is open to anyone who has ever been diagnosed with a melanoma of the skin, or of the mucosal surfaces (e.g. nose, genitals).
To sign up, or for more information, visit the website: www.mymelanomastudy.org
Completed Research Studies
SHP participated in an investigation of lifestyle, environmental, genomic and molecular factors underlying health outcomes in South Asians and Europeans – the LOLIPOP 100K study.
SHP are grateful for the 129 patients who participated in this study; contributing to the success of this study.
We participated in a study that took place at University Hospitals Birmingham (UHB) looking at Chronic Obstructive Pulmonary Disease (COPD).
The clinical study was carried out with patients with moderate to very severe Chronic Obstructive Pulmonary Disease (COPD), and has been conducted to see if a new precision drug called Benralizumab can help control COPD better if it is added to available COPD inhaled medications.